Skip to main content
Erschienen in: Annals of Nuclear Medicine 3/2010

01.04.2010 | Original Article

An efficient and aseptic preparation of “sodium fluoride (18F) injection” in a GMP compliant facility

verfasst von: Chih-Hao K. Kao, Wen-Lin Hsu, Pan-Fu Kao, Wen-Chun Lan, Heng-Li Xie, Ming-Chi Lin, Hao-Yu Chao

Erschienen in: Annals of Nuclear Medicine | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Introduction

“Sodium fluoride (18F) injection” is an isotonic NaCl solution containing [18F]NaF to be used as bone imaging agent. Although its NDA was approved by the US FDA in 1972, it has not been commercially available since 1975 due to mostly the popularity of 99mTc-MDP. Recently, advances in PET/CT technology and the often interrupted 99mTc supply have led to the renewed interest in the use of [18F]NaF to detect bone metastases in cancer patients. This report introduces an efficient, low-cost and aseptic preparation of “Sodium fluoride (18F) injection” for PET scan.

Method

18F-Fluoride in target water from cyclotron was adsorbed onto four different forms of anion-exchange resins then desorbed by isotonic NaCl solution into the product vial. One of the resins that yielded the product at the suitable pH was used for the aseptic preparation. The components for this setup, including stopcocks, extension tubes, etc., were all single-use, individually packed and sterile. The process was done in a lead-line isolator maintained in grade A (PIC/S) aseptic condition. The quality of the obtained “Sodium fluoride (18F) injection” was analyzed according to its monograph in the European Pharmacopoeia (EP).

Results

The resin in the chloride form yielded the product of pH 6.7 and was chosen for the subsequent preparation. The radiochemical yield was quantitative. The product met all criteria specified in EP, including biological, physical and chemical specifications.

Conclusions

This method is an efficient, space-saving and extremely low-cost operation that easily performed in an aseptic environment meeting GMP standard. The quality of the “Sodium fluoride (18F) injection” so yielded meets EP specifications. This setup provides hospital with facility meeting GMP standard a cost effective and efficient method for “Sodium fluoride (18F) injection” production without the need for the expensive automatic module and extra QC instrument.
Literatur
1.
Zurück zum Zitat Council of Europe. Radiopharmaceutical preparations: sodium fluoride (18F) injection. In: European Pharmacopoeia. 6th ed. 2008. p. 1008–9. Council of Europe. Radiopharmaceutical preparations: sodium fluoride (18F) injection. In: European Pharmacopoeia. 6th ed. 2008. p. 1008–9.
2.
Zurück zum Zitat United States Pharmacopeial Convention. Monographs: sodium fluoride F 18 Injection. In: USP31/NF26, vol. 2; 2008. p. 2195. United States Pharmacopeial Convention. Monographs: sodium fluoride F 18 Injection. In: USP31/NF26, vol. 2; 2008. p. 2195.
3.
Zurück zum Zitat Schirrmeister H, Guhlmann A, Elsner K, Kotzerke J, Glatting G, Rentschler M, et al. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. J Nucl Med. 1999;40:1623–9.PubMed Schirrmeister H, Guhlmann A, Elsner K, Kotzerke J, Glatting G, Rentschler M, et al. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET. J Nucl Med. 1999;40:1623–9.PubMed
4.
Zurück zum Zitat Schirrmeister H, Guhlmann A, Kotzerke J, Santjohanser C, Kühn T, Kreienberg R, et al. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol. 1999;17:2381–9.PubMed Schirrmeister H, Guhlmann A, Kotzerke J, Santjohanser C, Kühn T, Kreienberg R, et al. Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. J Clin Oncol. 1999;17:2381–9.PubMed
5.
Zurück zum Zitat Schirrmeister H, Glatting G, Hetzel J, Nüssle K, Arslandemir C, Buck AK, et al. Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med. 2001;42:1800–4.PubMed Schirrmeister H, Glatting G, Hetzel J, Nüssle K, Arslandemir C, Buck AK, et al. Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer. J Nucl Med. 2001;42:1800–4.PubMed
6.
Zurück zum Zitat Hetzel M, Arslandemir C, König HH, Buck AK, Nüssle K, Glatting G, et al. F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management. J Bone Miner Res. 2003;18:2206–14.CrossRefPubMed Hetzel M, Arslandemir C, König HH, Buck AK, Nüssle K, Glatting G, et al. F-18 NaF PET for detection of bone metastases in lung cancer: accuracy, cost-effectiveness, and impact on patient management. J Bone Miner Res. 2003;18:2206–14.CrossRefPubMed
7.
Zurück zum Zitat Even-Sapir E, Metser U, Flusser G, Zuriel L, Kollender Y, Lerman H, et al. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 8F-fluorid PET/CT. J Nucl Med. 2004;45:272–8.PubMed Even-Sapir E, Metser U, Flusser G, Zuriel L, Kollender Y, Lerman H, et al. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 8F-fluorid PET/CT. J Nucl Med. 2004;45:272–8.PubMed
8.
Zurück zum Zitat National Research Council. Molybdenum-99/Technetium-99m Supply Reliability. In: Medical isotope production without highly enriched uranium. Washington D.C.: The National Academies Press; 2009. p. 55–65. National Research Council. Molybdenum-99/Technetium-99m Supply Reliability. In: Medical isotope production without highly enriched uranium. Washington D.C.: The National Academies Press; 2009. p. 55–65.
9.
Zurück zum Zitat National Research Council. Medical isotope production without highly enriched uranium. Washington D.C.: The National Academies Press; 2009. National Research Council. Medical isotope production without highly enriched uranium. Washington D.C.: The National Academies Press; 2009.
12.
13.
Zurück zum Zitat Mazza SM, Yoshizumi T. 48V radionuclide impurity in product streams from liquid cyclotron targets with titanium windows. Nucl Med Biol. 1994;21:677–9.CrossRefPubMed Mazza SM, Yoshizumi T. 48V radionuclide impurity in product streams from liquid cyclotron targets with titanium windows. Nucl Med Biol. 1994;21:677–9.CrossRefPubMed
14.
Zurück zum Zitat Lee SJ, Oh SJ, Chi DY, Kil HS, Kim EN, Ryu JS, et al. Simple and highly efficient synthesis of 3′-deoxy-3′-[18F]fluorothymidine using nucleophilic fluorination catalyzed by protic solvent. Eur J Nucl Med Mol Imaging. 2007;34:1406–9.CrossRefPubMed Lee SJ, Oh SJ, Chi DY, Kil HS, Kim EN, Ryu JS, et al. Simple and highly efficient synthesis of 3′-deoxy-3′-[18F]fluorothymidine using nucleophilic fluorination catalyzed by protic solvent. Eur J Nucl Med Mol Imaging. 2007;34:1406–9.CrossRefPubMed
15.
Zurück zum Zitat United States Pharmacopeial Convention. Reagents, indicators, and solutions: chromatographic reagents. In: USP31/NF26, vol. 1; 2008. p. 810–2. United States Pharmacopeial Convention. Reagents, indicators, and solutions: chromatographic reagents. In: USP31/NF26, vol. 1; 2008. p. 810–2.
16.
Metadaten
Titel
An efficient and aseptic preparation of “sodium fluoride (18F) injection” in a GMP compliant facility
verfasst von
Chih-Hao K. Kao
Wen-Lin Hsu
Pan-Fu Kao
Wen-Chun Lan
Heng-Li Xie
Ming-Chi Lin
Hao-Yu Chao
Publikationsdatum
01.04.2010
Verlag
Springer Japan
Erschienen in
Annals of Nuclear Medicine / Ausgabe 3/2010
Print ISSN: 0914-7187
Elektronische ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-010-0343-4

Weitere Artikel der Ausgabe 3/2010

Annals of Nuclear Medicine 3/2010 Zur Ausgabe